메뉴 건너뛰기




Volumn 106, Issue 8, 1997, Pages 640-642

Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3)

Author keywords

Immunosuppression; OKT3; Sensorineural hearing loss; Transplant

Indexed keywords

OKT 3;

EID: 8544245667     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949710600804     Document Type: Article
Times cited : (14)

References (8)
  • 2
    • 0027050484 scopus 로고
    • Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity
    • Wallach PM, Love SR, Fiorica JV, Hoffman MS, Flannery MT. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity. J Fla Med Assoc 1992;79:821-2.
    • (1992) J Fla Med Assoc , vol.79 , pp. 821-822
    • Wallach, P.M.1    Love, S.R.2    Fiorica, J.V.3    Hoffman, M.S.4    Flannery, M.T.5
  • 3
    • 0018701862 scopus 로고
    • Monoclonal antibodies defining distinctive T cell surface antigens
    • Kung PC, Goldstein G, Reinherz EL, Schlossman SF. Monoclonal antibodies defining distinctive T cell surface antigens. Science 1979;206:347-9.
    • (1979) Science , vol.206 , pp. 347-349
    • Kung, P.C.1    Goldstein, G.2    Reinherz, E.L.3    Schlossman, S.F.4
  • 4
    • 0024676035 scopus 로고
    • Muromonab CD3: A review of its pharmacology and therapeutic potential
    • Todd P, Brogden RN. Muromonab CD3: a review of its pharmacology and therapeutic potential. Drugs 1989;37:871-99.
    • (1989) Drugs , vol.37 , pp. 871-899
    • Todd, P.1    Brogden, R.N.2
  • 5
    • 0021816056 scopus 로고
    • A random- Ized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants
    • Ortho Multicenter Transplant Study Group. A random- ized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985;313:337-42.
    • (1985) N Engl J Med , vol.313 , pp. 337-342
  • 6
    • 0023834380 scopus 로고
    • Monitoring and complications of monoclonal therapy: Complications and monitoring of OKT3 therapy
    • Thistlethwaite JR Jr, Stuart JK, Mayes JT, et al. Monitoring and complications of monoclonal therapy: complications and monitoring of OKT3 therapy. Am J Kidney Dis 1988;9:112-9.
    • (1988) Am J Kidney Dis , vol.9 , pp. 112-119
    • Thistlethwaite Jr., J.R.1    Stuart, J.K.2    Mayes, J.T.3
  • 7
    • 0026071251 scopus 로고
    • OKT3 first dose reaction: Association with T cell subsets and cytokine release
    • Gaston RS, Deierhoi MH, Patterson T, et al. OKT3 first dose reaction: association with T cell subsets and cytokine release. Kidney Int 1991;39:141-8.
    • (1991) Kidney int , vol.39 , pp. 141-148
    • Gaston, R.S.1    Deierhoi, M.H.2    Patterson, T.3
  • 8
    • 0026333962 scopus 로고
    • Growth factor interactions in cultures of dissociated adult acoustic ganglia: Neuronotrophic effects
    • Lefebvre PP, Van De Water TR, Weber T, Rogister B, Moonen G. Growth factor interactions in cultures of dissociated adult acoustic ganglia: neuronotrophic effects. Brain Res 1991;567:306-12.
    • (1991) Brain Res , vol.567 , pp. 306-312
    • Lefebvre, P.P.1    Van De Water, T.R.2    Weber, T.3    Rogister, B.4    Moonen, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.